目次

Table of Contents

1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary

2. Strategic Recommendations

3. Global Pain Management Drugs Market: Product Overview

4. Global Pain Management Drugs Market: Pipeline Analysis
4.1. Competitive Positioning of Prominent companies with Pain management Drugs in their Pipeline
4.2 Investigational New Drug
4.2.1 Basimglurant (NOE-101), Drug Description and Outcomes
4.3 Phase I
4.3.1 Resiniferatoxin (RTX), Drug Description and Outcomes
4.3.2 VX-548, Drug Description and Outcomes
4.4 Phase - II/III
4.4.1 TLC590, Bupivacaine, Drug Description and Outcomes
4.5 Phase II
4.5.1 BAY2395840, Drug Description and Outcomes
4.5.2 Libvatrep- SAF312, Drug Description and Outcomes
4.5.3 Trametinib, Drug Description and Outcomes
4.5.4 Canakinumab + LNA043, Drug Description and Outcomes
4.5.5 Erenumab-aooe (EREN), Drug Description and Outcomes
4.5.6 Erenumab-Aooe (AimovigÆ), Drug Description and Outcomes
4.5.7 Erenumab-Aooe 70 MG, Drug Description and Outcomes
4.5.8 BOTOX (onabotulinumtoxinA) , Drug Description and Outcomes
4.5.9 Resiniferatoxin, Drug Description and Outcomes
4.5.10 Resiniferatoxin, Zilretta, Drug Description and Outcomes
4.5.11 LY3526318, Drug Description and Outcomes
4.5.12 LY3526318, Drug Description and Outcomes
4.5.13 Quinagolide (FE 999051), Drug Description and Outcomes
4.5.14 HMI-115, Drug Description and Outcomes
4.6 Phase III
4.6.1 Secukinumab, Drug Description and Outcomes
4.6.2 Venglustat (GZ402671) , Drug Description and Outcomes
4.6.3 Elagolix + Estradiol/Norethindrone Acetate, Drug Description and Outcomes
4.6.4 Elagolix + Combined Oral Contraceptive (COC), Drug Description and Outcomes
4.6.5 Ibuprofen PR (300 mg and 200 mg), Drug Description and Outcomes
4.6.6 Ibuprofen Liquid Capsules (200 mg), Drug Description and Outcomes
4.6.7 Intravenous (IV) tramadol (AVE-901), Drug Description and Outcomes
4.7 Phase IV
4.7.1 Catapresan, Drug Description and Outcomes
4.7.2 Ubrogepant 50 MG, 100MG, Drug Description and Outcomes Galcanezumab, Drug Description and Outcomes Erenumab Prefilled Syringe, Drug Description and Outcomes

5. Global Pain Management Drugs Market: An Analysis
5.1. Assessment of Macro-Economic Indicators of Global Pain Management Drugs Market
5.2. Pain Management Drugs Market
5.3 Market Size, By Value, 2018-2028
5.4 Global Pain Management Drugs Market: Growth and Forecast
5.5 Impact of COVID-19 on Global Pain Management Drugs Market

6. Global Pain Management Drugs Market: Segment Analysis By Drug Type
6.1 Global Pain Management Drugs Market Segmentation, By Drug Type
6.2 Competitive Positioning of Pain Management Drugs Market: By Drug Type (2021 & 2028)
6.3 By Acetaminophen, By Value (USD Million), 2018-2028
6.4 By NSAIDs, By Value (USD Million), 2018-2028
6.5 By Narcotics (opioids), By Value (USD Million), 2018-2028
6.6 By Others, By Value (USD Million), 2018-2028

7. Global Pain Management Drugs Market: Segment Analysis By Route of Administration
7.1 Global Pain Management Drugs Market Segmentation, By Route of Administration
7.2 Competitive Positioning of Pain Management Drugs Market: By Route of Administration (2021 & 2028)
7.3 By Topical, By Value (USD Million), 2018-2028
7.4 By Intravenous, By Value (USD Million), 2018-2028
7.5 By Oral, By Value (USD Million), 2018-2028
7.6 By Others, By Value (USD Million), 2018-2028

8. Global Pain Management Drugs Market: Segment Analysis By End Use
8.1 Global Pain Management Drugs Market Segmentation, By End Use
8.2 Competitive Positioning of Pain Management Drugs Market: By End Use (2021 & 2028)
8.3 By Inflammation, By Value (USD Million), 2018-2028
8.4 By Neuropathic Pain, By Value (USD Million), 2018-2028
8.5 By Musculoskeletal Pain, By Value (USD Million), 2018-2028
8.6 By Severe and Chronic Pain, By Value (USD Million), 2018-2028

9. Global Pain Management Drugs Market: Segment Analysis By Availability
9.1 Global Pain Management Drugs Market Segmentation, By Availability
9.2 Competitive Positioning of Pain Management Drugs Market: By Availability (2021 & 2028)
9.3 By Prescription, By Value (USD Million), 2018-2028
9.4 By Over The Counter (OTC), By Value (USD Million), 2018-2028

10. Global Pain Management Drugs Market: Segment Analysis
10.1 Global Pain Management Drugs Market Segmentation, By Sales Channel
10.2 Competitive Positioning of Pain Management Drugs Market: By Sales Channel (2021 & 2028)
10.3 By Hospital Pharmacies, By Value (USD Million), 2018-2028
10.4 By Retail Pharmacies, By Value (USD Million), 2018-2028
10.5 By E-commerce, By Value (USD Million), 2018-2028

11. Global Pain Management Drugs Market: Regional Analysis
11.1 Competitive Positioning of Global Pain Management Drugs Market: By Region (2021 & 2028)

12. Americas Pain Management Drugs Market: An Analysis (2018-2028)
12.1 Assessment of Macro-Economic Indicators of Americas Pain Management Drugs Market
12.2 Americas Pain Management Drugs Market- Size and Forecast, By Value (2018-2028)
12.3 Americas Pain Management Drugs Market
12.4 Americas Pain Management Drugs Market: Prominent Companies
12.5 Americas Pain Management Drugs Market: Segment Analysis
12.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics (opioids), Others) By Value
12.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
12.8 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
12.9 Market Segmentation By Availability (OTC, Prescription), By Value
12.10 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
12.13 Americas Pain Management Drugs Market: Country Analysis
12.14 Market Opportunity Chart of Americas Pain Management Drugs Market - By Country, By Value (Year-2028)
12.15 Competitive Positioning of Americas Pain Management Drugs Market - By Country
12.16 United States Pain Management Drugs Market: Size and Forecast (2018-2028)
12.17 United States Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration, By End use, By Availability By Sales Channel (2018-2028)
12.18 Canada Pain Management Drugs Market: Size and Forecast (2018-2028)
12.19 Canada Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)

13. Europe Pain Management Drugs Market: An Analysis (2018-2028)
13.1 Assessment of Macro-Economic Indicators of Europe Pain Management Drugs Market
13.2 Europe Pain Management Drugs Market By value: Size and Forecast (2018-2028)
13.3 Europe Pain Management Drugs Market
13.4 Europe Pain Management Drugs Market: Prominent Companies
13.5 Europe Pain Management Drugs Market: Segment Analysis
13.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Narcotics (opioids), Others) By Value
13.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
13.4 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
13.5 Market Segmentation By Availability (OTC, Prescription), By Value
13.6 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
13.7 Europe Pain Management Drugs Market: Country Analysis
13.8 Market Opportunity Chart of Europe Pain Management Drugs Market - By Country, By Value (Year-2028)
13.9 Competitive Positioning of Europe Pain Management Drugs Market - By Country
13.10 Germany Pain Management Drugs Market: Size and Forecast (2018-2028)
13.11 Germany Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
13.12 United Kingdom Pain Management Drugs Market: Size and Forecast (2018-2028)
13.13 United Kingdom Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
13.14 France Pain Management Drugs Market: Size and Forecast (2018-2028)
13.15 France Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
13.16 Spain Pain Management Drugs Market: Size and Forecast (2018-2028)
13.17 Spain Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)
13.18 Italy Pain Management Drugs Market: Size and Forecast (2018-2028)
13.19 Italy Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End-use, By Availability, By Sales Channel (2018-2028)

14 APAC Pain Management Drugs Market: An Analysis (2018-2028)
14.1 Assessment of Macro-Economic Indicators of APAC Pain Management Drugs Market
14.2 APAC Pain Management Drugs Market By value: Size and Forecast (2018-2028)
14.3 APAC Pain Management Drugs Market
14.4 APAC Pain Management Drugs Market: Prominent Companies
14.5 APAC Pain Management Drugs Market: Segment Analysis
14.6 Market Segmentation By Drug Type (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs) , Narcotics (opioids), Others) By Value
14.7 Market Segmentation By Route of Administration (Topical, Intravenous, Oral, Others) By Value
14.8 Market Segmentation By End Use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Severe and Chronic Pain), By Value
14.9 Market Segmentation By Availability (OTC, Prescription), By Value
14.10 Market Segmentation By Sales Channel (Hospital pharmacies, retail pharmacies, e-commerce), By Value
14.11 APAC Pain Management Drugs Market: Country Analysis
14.12 Market Opportunity Chart of APAC Pain Management Drugs Market - By Country, By Value (Year-2028)
14.13 Competitive Positioning of APAC Pain Management Drugs Market - By Country
14.14 China Pain Management Drugs Market: Size and Forecast (2018-2028)
14.15 China Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
14.16 Japan Pain Management Drugs Market: Size and Forecast (2018-2028)
14.7 Japan Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)
14.8 India Pain Management Drugs Market: Size and Forecast (2018-2028)
14.9 India Pain Management Drugs Market Segmentation By Drug Type, By Route of Administration and, By End use, By Availability, By Sales Channel (2018-2028)

15. Middle East and Africa Pain Management Drugs Market
15.1 Assessment of Macro-Economic Indicators of MEA Pain Management Drugs Market
15.2 Middle East and Africa Pain Management Drugs Market By value: Size and Forecast (2018-2028)
15.3 Market Segmentation By Drug Type (Antibiotics, Antifungals, Astringents, Antipruritic, Analgesics, Others)
15.4 Market Segmentation By Route of Administration (Skin Disease, Pain Management, Eye and Ear Care, Others), By Value
15.5 Market Segmentation By End use (Inflammation, Neuropathic Pain, Musculoskeletal Pain, Others), By Value
15.6 Market Segmentation By Availability (Prescription, Over The Counter (OTC), Others), By Value
15.7 Market Segmentation By Sales Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Value

16. Global Pain Management Drugs Market Dynamics
16.1 Global Pain Management Drugs Market Drivers
16.2 Global Pain Management Drugs Market Restraints
16.3 Global Pain Management Drugs Market Trends

17. Market Attractiveness and Strategic Analysis
17.1 Market Attractiveness Chart of Global Pain Management Drugs Market - By Drug Type (2028)
17.2 Market Attractiveness Chart of Global Pain Management Drugs Market - By Route of Administration (2028)
17.3 Market Attractiveness Chart of Global Pain Management Drugs Market - By End-use (2028)
17.4 Market Attractiveness Chart of Global Pain Management Drugs Market - By Availability (2028)
17.5 Market Attractiveness Chart of Global Pain Management Drugs Market - By Sales Channel (2028)
17,6 Market Attractiveness Chart of Global Pain Management Drugs Market - By Region (2028)

18. Competitive Landscape
18.1 Market Share of global leading companies

19. Company Profiles (Business Description, Financial Analysis, Business Strategy)
19.1 Pfizer Inc.
19.2 Johnson & Johnson
19.3 GSK plc.
19.4 Bristol-Myers Squibb Company
19.5 Bayer AG
19.6 Boehringer Ingelheim
19.7 AbbVie Inc.
19.8 Teva pharmaceuticals
19.9 Sanofi
19.10 Amgen

List of Figures
Figure 1: Global Urban Population (2016-2020) (% of total)
Figure 2: Global Aged Population (Above 65), 2015-20 (% of total Population)
Figure 3: Global Aged Population(Above 65), By Country, 2020 (% of total Population)
Figure 4: Global Medical Spending in 2020, By Region, (% of Total)
Figure 5: Total number of hospitals in select countries worldwide in 2019-20
Figure 6: Current Healthcare Expenditure (% Share of GDP), By Selected Country, 2016-2020 (In %)
Figure 7: Estimated global prevalence and numbers of adults living with obesity (Obesity (Class I, II and III) BMI =30kg/m2 in 2010 -2030
Figure 8: Age-adjusted comparative prevalence of diabetes, % (2000-2045)
Figure 9: Global Expected Healthcare Industry Outlook
Figure 10: Regional Expected Healthcare Industry Growth Rate By Year 2024
Figure 11: Global Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 12: Global Estimated number of Cancer Types with high prevalence of pain (incidences and prevalent cases)(all ages, in millions), Year 2019
Figure 13: Global Incidence of Road injuries,(in Millions), 2019
Figure 14: Incidence of Injury from Fire, heat, and hot substances (In million), Year 2019
Figure 15: Global Pain Management Drugs Market- By Drug Type , Market Share, 2021 & 2028
Figure 16: Global Pain Management Drugs Market- By Drug Type , By Acetaminophen (USD Million), 2018-2028
Figure 17: Global Pain Management Drugs Market- By Drug Type , By NSAIDs, By Value (USD Billion), 2018-2028
Figure 18: Global Pain Management Drugs Market- By Drug Type , By Narcotics (opioids), By Value (USD Billion), 2018-2028
Figure 19: Global Pain Management Drugs Market- By Drug Type , By Others , By Value (USD Billion), 2018-2028
Figure 20: Global Pain Management Drugs Market- By Route of Administration Market Share, 2021 & 2028
Figure 21: Global Pain Management Drugs Market- By Route of Administration , By Topical Route (USD Billion), 2018-2028
Figure 22: Global Pain Management Drugs Market- By Route of Administration , By Intravenous Route (USD Billion), 2018-2028
Figure 23: Global Pain Management Drugs Market- By Route of Administration , By Oral Route (USD Billion), 2018-2028
Figure 24: Global Pain Management Drugs Market- By Route of Administration , By Others (USD Billion), 2018-2028
Figure 25: Global Pain Management Drugs Market- By End use, Market Share, 2021 & 2028
Figure 26: Global Pain Management Drugs Market- By End use, By Inflammation, By Value (USD Billion), 2018-2028
Figure 27: Global Pain Management Drugs Market- By End use, By Neuropathic Pain, By Value (USD Billion), 2018-2028
Figure 28: Global Pain Management Drugs Market- By End use, By Musculoskeletal Pain, By Value (USD Billion), 2018-2028
Figure 29: Global Pain Management Drugs Market- By End use, By Severe and Chronic Pain, By Value (USD Billion), 2018-2028
Figure 30: Global Pain Management Drugs Market- By Availability Market Share, 2021 & 2028
Figure 31: Global Pain Management Drugs Market- By Availability, By Prescription (USD Billion), 2018-2028
Figure 32: Global Pain Management Drugs Market- By Availability, By Over The Counter (OTC), By Value (USD Billion), 2018-2028
Figure 33: Global Pain Management Drugs Market- By Sales Channel Market Share, 2021 & 2028
Figure 34: Global Pain Management Drugs Market- By Sales Channel, By Hospital Pharmacies, By Value (USD Billion), 2018-2028
Figure 35: Global Pain Management Drugs Market- By Sales Channel, By Retail Pharmacies, By Value (USD Billion), 2018-2028
Figure 36: Global Pain Management Drugs Market- By Sales Channel, By E-commerce , By Value (USD Billion), 2018-2028
Figure 37: Global Pain Management Drugs Market- By Region Market Share, 2021 & 2028
Figure 38: North America Population (in Millions), 2018-2021
Figure 39: North America Population ages 65 and above (% of total Population), 2016-2020
Figure 40: North America Current health expenditure per capita (current USD), 2015-19
Figure 41: Latin America Population (in Millions), 2018-2021
Figure 42: Incidence of Cancer in North and South America, (in million), 2020
Figure 43: Incidence of Road injuries in Region of the Americas, (in million), 2016-2019
Figure 44: Incidence of injuries from Fire, heat, and hot substances in Region of Americas, 2016-2019, (in millions)
Figure 45: Prevalence of Osteoarthritis in Region of Americas, 2015-2019, (in millions)
Figure 46: Prevalence of Diabetes in Regions of America, (in million), 2021
Figure 47: Incidence of Appendicitis in Region of the Americas, (in million), 2016-2019
Figure 48: Prevalence of chronic Low back and Neck Pain in Region of Americas, 2016-2019, (in millions)
Figure 49: Americas Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 50: Americas Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 51: Americas Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 52: Americas Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 53: Americas Pain Management Drugs Market- By Availability , By Value (USD Billion), 2018-2028
Figure 54: Americas Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 55: Market Opportunity Chart of Americas Pain Management Drugs Market- By Country, By Value (Year-2028)
Figure 56: Americas Pain Management Drugs Market- By Country Market Share, 2021 & 2028
Figure 57: United States Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 58: United States Pain Management Drugs Market- By Drug Type , By Value (USD Million), 2018-2028
Figure 59: United States Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 60: United States Pain Management Drugs Market- By End use, By Value (USD Million), 2018-2028
Figure 61: United States Pain Management Drugs Market- By Availability , By Value (USD Million), 2018-2028
Figure 62: United States Pain Management Drugs Market- By Sales Channel, By Value (USD Million), 2018-2028
Figure 63: Canada Pain Management Drugs Market Size, By Value, 2018-2028 (USD Million)
Figure 64: Canada Pain Management Drugs Market- By Drug Type , By Value (USD Million), 2018-2028
Figure 65: Canada Pain Management Drugs Market- By Route of Administration , By Value (USD Million), 2018-2028
Figure 66: Canada Pain Management Drugs Market- By End use, By Value (USD Million), 2018-2028
Figure 67 : Canada Pain Management Drugs Market- By Availability , By Value (USD Million), 2018-2028
Figure 68: Canada Pain Management Drugs Market- By Sales Channel, By Value (USD Million), 2018-2028
Figure 69: European Union Population (in Millions), 2017-2020
Figure 70: Population ages 65 and above (% of total Population) in European Countries, 2020
Figure 71: European Union Current health expenditure per capita (current USD), 2015-19
Figure 72: Total expenditure on health per capita in European countries (in USD PPP), 2019
Figure 73: Incidence of Cancer in Europe, (in million), 2016-2019
Figure 74: Incidence of Road Injuries in Europe , 2016-2019 (In Million)
Figure 75: Incidence of Injuries from Fire, heat, and hot substances in Europe (all ages, in Million), Year 2016-2019
Figure 76: Prevalence of Osteoarthritis Diseases in Europe, (in Million), 2015-2019
Figure 77: Estimated Prevalence of Diabetes in Europe, (in million), 2011, 2021, 2030(E),2045(E)
Figure 78: Incidence of Appendicitis in Europe, (in million), 2016-2019
Figure 79: Prevalence of chronic Low back and Neck Pain in Europe, 2016-2019, (in millions)
Figure 80: Europe Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 81: Europe Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 82: Europe Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 83: Europe Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 84: Europe Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 85: Europe Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 86: Market Opportunity Chart of Europe Pain Management Drugs Market- By Country, By Value (Year-2028)
Figure 87: Europe Pain Management Drugs Market- By Country Market Share, 2021 & 2028
Figure 88: Germany Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 89: Germany Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 90: Germany Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 91: Germany Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 92: Germany Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 93: Germany Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 94: United Kingdom Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 95: United Kingdom Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 96: United Kingdom Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 97: United kingdom Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 98: United Kingdom Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 99: United Kingdom Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 100: France Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 101: France Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 102: France Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 103: France Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 104: France Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 105: France Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 106: Spain Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 107: Spain Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 108: Spain Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 109: Spain Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 110: Spain Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 111: Spain Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 112: Italy Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 113: Italy Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 114: Italy Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 115: Italy Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 116: Italy Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 117: Italy Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 118: Asia Pacific, Population ages 65 and above (% of total Population), 2016-20
Figure 119: Asia Pacific Population ages 65 and above, By Countries (% of total Population), 2020
Figure 120: Asia Pacific Current health expenditure per capita (current USD), 2014-18
Figure 121: Asia Pacific, Current health expenditure per capita, By countries (current USD), 2019
Figure 122: East Asia and Pacific Population (in Billion), 2018-2020
Figure 123: Prevalence of Osteoarthritis Diseases in Asia Pacific, (in million), 2015-2019
Figure 124: Incidence of Cancer in Asia, By countries (in million), 2020
Figure 125: Incidence of Road Injuries in Asia , 2016-2019 (In Million)
Figure 126: Estimated Prevalence of Diabetes in South-East Asia, (in million), 2011, 2021, 2030(E),2045(E)
Figure 127: Incidence of Appendicitis in Asia, (in million), 2016-2019
Figure 128: Prevalence of chronic Low back and Neck Pain in Europe, 2016-2019, (in millions)
Figure 129: Incidence of Injuries from Fire, heat, and hot substances in Asia (all ages, in Million), Year 2016-2019
Figure 130: Asia Pacific Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 131: Asia Pacific Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 132 Asia Pacific Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 133 Asia Pacific Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 134 Asia Pacific Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 135 Asia Pacific Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 136 Market Opportunity Chart of APAC Pain Management Drugs Market- By Country, By Value (Year-2028)
Figure 137 APAC Pain Management Drugs Market- By Country Market Share, 2021 & 2028
Figure 138 China Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 139 China Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 140 China Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 141 China Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 142: China Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 143: China Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 144: Japan Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 145: Japan Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 146: Japan Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 147: Japan Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 148: Japan Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 149: Japan Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 150: India Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 151: India Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 152: India Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 153: India Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 154: India Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 155: India Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 156: Middle East and North Africa Population(in Million), 2018-2020
Figure 157: Middle East and North Africa, GDP Per Capita, value (USD Million), 2018-2020
Figure 158: Middle East and North Africa, Population ages 65 and above (% of total population), 2016-19
Figure 159: Middle East and North Africa, Incidence of Osteoarthritis (in millions), 2016-19
Figure 160: Incidence of Cancer in AFRO, By countries (ASR per 100,000), 2020
Figure 161: Incidence of Injuries from Fire, heat, and hot substances in North Africa and Middle East (all ages, in Million), Year 2016-2019
Figure 162: Incidence of Road Injuries in North Africa and Middle East , 2016-2019 (In Million)
Figure 163: Estimated Prevalence of Diabetes in Middle East and North Africa, (in million), 2011, 2021, 2030(E),2045(E)
Figure 164: Incidence of Appendicitis in North Africa and Middle East , (in thousands), 2016-2019
Figure 165: Prevalence of chronic Low back and Neck Pain in North Africa and Middle East , 2016-2019, (in millions)
Figure 166: Middle East and Africa Pain Management Drugs Market Size, By Value, 2018-2028 (USD Billion)
Figure 167: Middle East and Africa Pain Management Drugs Market- By Drug Type , By Value (USD Billion), 2018-2028
Figure 168: Middle East and Africa Pain Management Drugs Market- By Route of Administration , By Value (USD Billion), 2018-2028
Figure 169: Middle East and Africa Pain Management Drugs Market- By End use, By Value (USD Billion), 2018-2028
Figure 170: Middle East and Africa Pain Management Drugs Market- By Availability, By Value (USD Billion), 2018-2028
Figure 171: Middle East and Africa Pain Management Drugs Market- By Sales Channel, By Value (USD Billion), 2018-2028
Figure 172: Market Attractiveness Chart of Global Pain Management Drugs Market- By Drug Type (Year-2028)
Figure 173: Market Attractiveness Chart of Global Pain Management Drugs Market- By Route of Administration (Year-2028)
Figure 174: Market Attractiveness Chart of Global Pain Management Drugs Market- By End use (Year-2028)
Figure 175: Market Attractiveness Chart of Global Pain Management Drugs Market- By Availability (Year-2028)
Figure 176: Market Attractiveness Chart of Global Pain Management Drugs Market- By Sales Channel (Year-2028)
Figure 177: Market Attractiveness Chart of Global Pain Management Drugs Market- By Region (Year-2028)
Figure 178: Global Pain Management Drugs Market Share (%), 2021
Figure 179: PFIZER Inc. Annual Sales Revenue, 2017-2021 (USD Million)
Figure 180: PFIZER Inc. Net Income, 2017-2021 (USD Million)
Figure 181: Pfizer Inc. Sales Revenue, By Business Segment (%), FY2021
Figure 182: Pfizer Inc. Sales Revenue, By Geographical Segment (%), FY2021
Figure 183: Johnson and Johnson Annual Sales Revenue, 2017-2021 (USD Million)
Figure 184: Johnson and Johnson Net Income, 2017-2021 (USD Million)
Figure 185: Johnson and Johnson Sales Revenue, By Business Segment (%), FY2021
Figure 186: Johnson and Johnson Sales Revenue, By Geographical Segment (%), FY2021
Figure 187: GSK plc. Annual Sales Revenue, 2017-2021 (USD Million)
Figure 188: GSK plc. Net Income, 2017-2021 (USD Million)
Figure 189: GSK plc. Sales Revenue, By Business Segment (%), FY2021
Figure 190: GSK plc. Sales Revenue, By Geographical Segment (%), FY2021
Figure 191: Bristol-Myers Squibb Annual Sales Revenue, 2017-2021 (USD Million)
Figure 192: Bristol-Myers Squibb Net Income, 2017-2021 (USD Million)
Figure 193: Bristol-Myers Squibb Sales Revenue, By Geographical Segment (%), FY2020
Figure 194: Bristol-Myers Squibb Sales Revenue, By Geographical Segment (%), FY2021
Figure 195: Bayer Annual Sales Revenue, 2017-2021 (USD Million)
Figure 196: Bayer Net Income, 2017-2021 (USD Million)
Figure 197: Bayer Sales Revenue, By Business Segment (%), FY2021
Figure 198: Bayer Sales Revenue, By Geographical Segment (%), FY2021
Figure 199: Boehringer Ingelheim Annual Sales Revenue, 2017-2021 (USD Million)
Figure 200: Boehringer Ingelheim Net Income, 2017-2021 (USD Million)
Figure 201: Boehringer Ingelheim Sales Revenue, By Business Segment (%), FY2021
Figure 202: Boehringer Ingelheim Sales Revenue, By Geographical Segment (%), FY2021
Figure 203: AbbVie Annual Sales Revenue, 2017-2021 (USD Million)
Figure 204: AbbVie Net Income, 2017-2021 (USD Million)
Figure 205: AbbVie Sales Revenue, By Business Segment (%), FY2021
Figure 206: AbbVie Sales Revenue, By Geographical Segment (%), FY2021
Figure 207: Teva Pharmaceuticals Annual Sales Revenue, 2017-2021 (USD Million)
Figure 208: Teva Pharmaceuticals Net Income, 2017-2021 (USD Million)
Figure 209: Teva Pharmaceuticals Sales Revenue, By Operating Segment (%), FY2020
Figure 210: Teva Pharmaceuticals Sales Revenue, By Operating Segment (%), FY2021
Figure 211: Sanofi Annual Sales Revenue, 2017-2021 (USD Million)
Figure 212: Sanofi Pharmaceuticals Net Income, 2017-2021 (USD Million)
Figure 213: Sanofi Sales Revenue, By Geographical Segment (%), FY2021
Figure 214: Sanofi Sales Revenue, By Business Segment (%), FY2021
Figure 215: Amgen Annual Sales Revenue, 2017-2021 (USD Million)
Figure 216: Amgen Pharmaceuticals Net Income, 2017-2021 (USD Million)
Figure 215: Amgen Sales Revenue, By Geographical Segment (%), FY2021
Figure 216: Amgen Sales Revenue, By Products (%), FY2021